Pathology Service - Home About Us Staff Divisions Clinical Services Education and Training Research Intranet
 
Pathology Service Staff
MGH Pathology Service | Last updated:  May 29, 2007



Atul K. Bhan, M.B.B.S., M.D.

Professor of Pathology, Harvard Medical School
Director of the Immunopathology Unit
Department of Pathology
Massachusetts General Hospital

Department of Pathology – WRN 501
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-726-2588
Fax: 617-726-2365
Email: abhan@partners.org

Affiliations:
Center for the Study of Inflammatory Bowel Disease,
Massachusetts General Hospital

 

Sign out: Liver transplantation, prognostic markers for breast cancer and autopsy.

Research Interests:

In the two major forms of IBD, Crohn’s disease and ulcerative colitis, the underlying etiological factors and the pathogenesis remain poorly defined. It is generally believed that exaggerated immune responses to luminal antigens due to loss of tolerance to normal enteric flora are involved in the initiation and perpetuation of the disease process. Whether IBD pathogenesis has an important autoimmune component has not been resolved yet.

The recent availability of a wide variety of experimental models of intestinal inflammation has helped provide important clues about the pathogenesis of IBD. The commonly used models include chemically induced mucosal injury and colitis induced by the transfer of selected populations of T cells into immunodeficient mice. The spontaneous development of colitis in genetically engineered animal models, including T cell receptor (TCR) alpha KO mice, and mice deficient in IL-2, IL-10, and the Wiskott- Aldrich syndrome protein (WASP) have provided excellent experimental models to study the pathogenesis of IBD. One important lesson learned from IBD models is that many different immunologic and mucosal defects can lead to similar pathologic findings.

For the last several years, our laboratory has focused on defining the pathogenesis of chronic intestinal inflammation using TCR alpha KO mice as a model of human IBD. TCR alpha KO mice develop spontaneously chronic colitis with many features of ulcerative colitis. These include restriction of inflammation to the colon and the mucosa, presence of autoantibodies, the protective role of appendectomy and pathogenic role of Th-2 pathway in the development of colitis. We have recently identified a regulatory B cell subset, which appears under chronic intestinal inflammatory conditions and suppresses the progression of intestinal inflammation by secreting IL-10. TCR alpha KO mice deficient in both IL-4 and B cells, but not in IL-4 alone, develop granulomatous colitis with features of Crohn’s disease. This suggests that differences in the two major forms of IBD may reflect different immunological responses to similar initiating events. The laboratory is closely associated with the Center for the Study of Inflammatory Bowel Disease at the MGH and collaborates with the other members of the Center. In collaboration with Dr. Cox Terhorst’s laboratory we have studied the pathogenesis of Th-1 mediated models of colitis in CD45RBhigh transfer model and bone marrow transplanted CD3 tg mice. In the first model, colitis can be induced by reconstitution of scid or Rag-2 KO mice with CD45RBhigh CD4+ T cells from wild type mice. In the second model, colitis develops after normal bone marrow cell reconstitution of T cell deficient CD3 tg mice. In both models, colitis develops due to lack of normal T cell regulation.

__________________________________________________________

Bibliography of Atul Bhan via Pubmed (will open in new window)

   
 
 
Send us a comment or suggestion
Page Updated: May 29, 2007
Privacy and Terms of Use